Filing Details
- Accession Number:
- 0001437749-25-019958
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-10 15:06:06
- Reporting Period:
- 2025-06-09
- Filing Date:
- 2025-06-10
- Accepted Time:
- 2025-06-10 15:06:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385818 | Aytu Biopharma Inc | AYTU | Pharmaceutical Preparations (2834) | 470883144 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640724 | Jarrett Disbrow | C/O Aytu Biopharma, Inc. 7900 East Union Avenue, Suite 920 Denver CO 80237 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-09 | 16,666 | $1.50 | 29,462 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025.
- Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023.